Nemaura Medical Inc. (NMRD)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 14.56 Million USD | -34.11% |
| 2022 | 22.1 Million USD | -37.29% |
| 2021 | 35.24 Million USD | 2788.71% |
| 2020 | 1.22 Million USD | -74.39% |
| 2019 | 4.76 Million USD | -23.85% |
| 2018 | 6.25 Million USD | -15.49% |
| 2017 | 7.4 Million USD | -23.95% |
| 2016 | 9.73 Million USD | 965.9% |
| 2015 | 913.1 Thousand USD | -55.45% |
| 2014 | 2.04 Million USD | 694.09% |
| 2013 | 258.12 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 8.45 Million USD | -41.98% |
| 2024 Q3 | 5.16 Million USD | -42.04% |
| 2024 Q2 | 8.91 Million USD | 5.55% |
| 2023 FY | 14.56 Million USD | -34.11% |
| 2023 Q3 | 12.96 Million USD | -18.49% |
| 2023 Q1 | 19.71 Million USD | -10.8% |
| 2023 Q4 | 14.56 Million USD | 12.36% |
| 2023 Q2 | 15.9 Million USD | -19.34% |
| 2022 Q1 | 35.68 Million USD | 1.25% |
| 2022 Q4 | 22.1 Million USD | -18.36% |
| 2022 FY | 22.1 Million USD | -37.29% |
| 2022 Q3 | 27.07 Million USD | -14.31% |
| 2022 Q2 | 31.59 Million USD | -11.46% |
| 2021 Q3 | 17.63 Million USD | -2.6% |
| 2021 Q4 | 35.24 Million USD | 99.8% |
| 2021 Q1 | 8.91 Million USD | 631.0% |
| 2021 Q2 | 18.1 Million USD | 103.05% |
| 2021 FY | 35.24 Million USD | 2788.71% |
| 2020 FY | 1.22 Million USD | -74.39% |
| 2020 Q4 | 1.22 Million USD | -43.61% |
| 2020 Q1 | 3.97 Million USD | -16.54% |
| 2020 Q2 | 2.7 Million USD | -31.99% |
| 2020 Q3 | 2.16 Million USD | -19.97% |
| 2019 Q3 | 5.74 Million USD | 31.16% |
| 2019 Q4 | 4.76 Million USD | -17.13% |
| 2019 Q1 | 5.57 Million USD | -10.92% |
| 2019 Q2 | 4.38 Million USD | -21.34% |
| 2019 FY | 4.76 Million USD | -23.85% |
| 2018 Q1 | 7.4 Million USD | 0.06% |
| 2018 Q2 | 6.99 Million USD | -5.55% |
| 2018 Q3 | 6.8 Million USD | -2.76% |
| 2018 Q4 | 6.25 Million USD | -8.04% |
| 2018 FY | 6.25 Million USD | -15.49% |
| 2017 Q4 | 7.4 Million USD | -5.85% |
| 2017 FY | 7.4 Million USD | -23.95% |
| 2017 Q3 | 7.86 Million USD | -8.48% |
| 2017 Q2 | 8.59 Million USD | -2.35% |
| 2017 Q1 | 8.79 Million USD | -9.61% |
| 2016 Q4 | 9.73 Million USD | -3.65% |
| 2016 Q2 | 379.56 Thousand USD | -31.22% |
| 2016 Q3 | 10.1 Million USD | 2561.44% |
| 2016 Q1 | 551.85 Thousand USD | -39.56% |
| 2016 FY | 9.73 Million USD | 965.9% |
| 2015 Q2 | 1.56 Million USD | -17.79% |
| 2015 FY | 913.1 Thousand USD | -55.45% |
| 2015 Q3 | 1.24 Million USD | -20.74% |
| 2015 Q4 | 913.1 Thousand USD | -26.41% |
| 2015 Q1 | 1.9 Million USD | -7.1% |
| 2014 Q3 | 81.01 Thousand USD | 0.0% |
| 2014 Q1 | - USD | -100.0% |
| 2014 Q4 | 2.04 Million USD | 2430.02% |
| 2014 FY | 2.04 Million USD | 694.09% |
| 2013 FY | 258.12 Thousand USD | 0.0% |
| 2013 Q4 | 258.12 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | 53.57% |
| BrainsWay Ltd. | 62.97 Million USD | 76.873% |
| Cerus Corporation | 197.74 Million USD | 92.635% |
| Envoy Medical, Inc. | 7.64 Million USD | -90.618% |
| electroCore, Inc. | 16.38 Million USD | 11.129% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -89.33% |
| IceCure Medical Ltd | 16.41 Million USD | 11.254% |
| Inogen, Inc. | 326.19 Million USD | 95.535% |
| OrthoPediatrics Corp. | 449.58 Million USD | 96.761% |
| Lucid Diagnostics Inc. | 27.27 Million USD | 46.596% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | 12.159% |
| MaxCyte, Inc. | 268.27 Million USD | 94.572% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -79.853% |
| Nexalin Technology, Inc. | 3.63 Million USD | -300.979% |
| Orthofix Medical Inc. | 925.31 Million USD | 98.426% |
| PAVmed Inc | 33.11 Million USD | 56.028% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 89.848% |
| RxSight, Inc. | 182.55 Million USD | 92.022% |
| Sight Sciences, Inc. | 166.65 Million USD | 91.261% |
| SI-BONE, Inc. | 230.42 Million USD | 93.68% |
| TELA Bio, Inc. | 78.04 Million USD | 81.341% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 94.219% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -35.724% |
| Acutus Medical, Inc. | 53.96 Million USD | 73.011% |
| Talis Biomedical Corporation | 98.34 Million USD | 85.191% |
| Spectral AI, Inc. | 10.69 Million USD | -36.207% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 93.339% |
| CVRx, Inc. | 115.22 Million USD | 87.361% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | 75.174% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -367.482% |
| Bioventus Inc. | 810.91 Million USD | 98.204% |
| Venus Concept Inc. | 93.65 Million USD | 84.45% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | 43.389% |
| LivaNova PLC | 2.42 Billion USD | 99.401% |
| 908 Devices Inc. | 202.98 Million USD | 92.825% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 98.191% |
| NeuroPace, Inc. | 107.65 Million USD | 86.472% |
| LENSAR, Inc. | 69.58 Million USD | 79.071% |
| Apyx Medical Corporation | 79.24 Million USD | 81.621% |
| Cutera, Inc. | 346.29 Million USD | 95.795% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | 65.339% |
| BioSig Technologies, Inc. | 1.79 Million USD | -709.968% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 94.619% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | 65.863% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 99.615% |
| Axonics, Inc. | 719.92 Million USD | 97.977% |
| Outset Medical, Inc. | 313.8 Million USD | 95.359% |
| IRIDEX Corporation | 34.43 Million USD | 57.709% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 96.402% |
| IRadimed Corporation | 92.15 Million USD | 84.197% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -177.184% |
| INVO Bioscience, Inc. | 20.88 Million USD | 30.279% |
| Telesis Bio, Inc. | 70.41 Million USD | 79.317% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 90.55% |
| Varex Imaging Corporation | 1.24 Billion USD | 98.835% |
| Quipt Home Medical Corp. | 247.4 Million USD | 94.114% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -56.426% |
| Pulmonx Corporation | 178.95 Million USD | 91.862% |
| Dynatronics Corporation | 25.94 Million USD | 43.859% |
| Modular Medical, Inc. | 13.8 Million USD | -5.477% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -35.762% |
| Semler Scientific, Inc. | 78.06 Million USD | 81.345% |
| InMode Ltd. | 863.28 Million USD | 98.313% |
| Bruker Corporation | 4.24 Billion USD | 99.657% |
| Cytosorbents Corporation | 53.26 Million USD | 72.657% |
| DexCom, Inc. | 6.26 Billion USD | 99.768% |
| Align Technology, Inc. | 6.08 Billion USD | 99.761% |
| Viveve Medical, Inc. | 25.91 Million USD | 43.8% |
| ZimVie Inc. | 1.2 Billion USD | 98.792% |
| Movano Inc. | 9.42 Million USD | -54.583% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 97.074% |
| Nexalin Technology, Inc. | 3.63 Million USD | -300.979% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | 75.174% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 98.471% |
| Profound Medical Corp. | 43.68 Million USD | 66.664% |
| Insulet Corporation | 2.58 Billion USD | 99.437% |
| enVVeno Medical Corporation | 48.63 Million USD | 70.056% |
| Surmodics, Inc. | 185.73 Million USD | 92.159% |
| iCAD, Inc. | 41.41 Million USD | 64.838% |
| Nuwellis, Inc. | 9.77 Million USD | -49.061% |
| Biotricity, Inc. | 5.94 Million USD | -145.064% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 96.638% |
| Aethlon Medical, Inc. | 8.24 Million USD | -76.61% |
| InspireMD, Inc. | 47.64 Million USD | 69.433% |
| PAVmed Inc. | 33.11 Million USD | 56.028% |
| BIOLASE, Inc. | 35.1 Million USD | 58.51% |
| Beyond Air, Inc. | 56.96 Million USD | 74.433% |
| FONAR Corporation | 214.24 Million USD | 93.203% |
| AxoGen, Inc. | 196.82 Million USD | 92.601% |
| Vivani Medical, Inc. | 45.79 Million USD | 68.2% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 94.825% |
| Inari Medical, Inc. | 674.23 Million USD | 97.84% |
| UFP Technologies, Inc. | 404.13 Million USD | 96.396% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | 37.76% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -53.247% |
| Tenon Medical, Inc. | 6.34 Million USD | -129.523% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -54.813% |
| Co-Diagnostics, Inc. | 103.64 Million USD | 85.949% |
| AdaptHealth Corp. | 4.61 Billion USD | 99.685% |
| Sintx Technologies, Inc. | 15.36 Million USD | 5.218% |
| NanoVibronix, Inc. | 6.67 Million USD | -118.208% |
| Quanterix Corporation | 425.01 Million USD | 96.573% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -56.426% |
| Sensus Healthcare, Inc. | 53.72 Million USD | 72.894% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 99.166% |
| TransMedics Group, Inc. | 706.04 Million USD | 97.937% |
| ReWalk Robotics Ltd. | 63.19 Million USD | 76.954% |
| NeuroMetrix, Inc. | 21.42 Million USD | 32.025% |
| Hyperfine, Inc. | 94.19 Million USD | 84.54% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 94.579% |
| Biomerica, Inc. | 9.25 Million USD | -57.372% |
| Bone Biologics Corporation | 3.73 Million USD | -289.624% |
| AVITA Medical, Inc. | 144.33 Million USD | 89.91% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -199.13% |
| Silk Road Medical, Inc | 265.3 Million USD | 94.511% |